【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 17
1.2 List of Figures 23
2 Introduction 26
2.1 Catalyst 26
2.2 Related Reports 27
2.3 Upcoming Related Reports 27
3 Disease Overview 28
3.1 Etiology and Pathophysiology 28
3.1.1 Etiology 28
3.1.2 Pathophysiology 29
3.1.3 Basic Breast Anatomy 30
3.2 Disease Classification/Staging Systems 31
3.3 Symptoms 33
3.4 Prognosis 33
3.5 Quality of Life 34
4 Epidemiology 37
4.1 Disease Background 37
4.2 Risk Factors and Comorbidities 37
4.2.1 A family history of breast cancer and BRCA1/2 gene mutations significantly increase the breast cancer risk 39
4.2.2 Reproductive hormonal factors influence the risk of breast cancer 39
4.2.3 Modifiable lifestyle-related factors increase the risk of mortality in breast cancer patients 41
4.2.4 Screening programs have been shown to reduce breast cancer mortality, although the benefits need to be carefully weighed against the risks 43
4.3 Global Trends 46
4.3.1 Incidence 46
4.3.2 Prevalence and Survival 52
4.4 Forecast Methodology 56
4.4.1 Sources Used 58
4.4.2 Sources Not Used 62
4.4.3 Forecast Assumptions and Methods 63
4.5 Epidemiological Forecast for Breast Cancer (2013-2023) – Diagnosed Incident Cases 66
4.5.1 Diagnosed Incident Cases of Breast Cancer 66
4.5.2 Diagnosed Incident Cases of Breast Cancer by Age 68
4.5.3 Diagnosed Incident Cases of Breast Cancer by Menopausal Status 70
4.5.4 Diagnosed Incident Cases of Breast Cancer Segmented by Stage at Diagnosis 72
4.5.5 Age-Standardized Diagnosed Incidence Rate of Breast Cancer 73
4.6 Epidemiological Forecast for Breast Cancer (2013-2023) — Diagnosed Prevalent Cases 74
4.6.1 Five-Year Diagnosed Prevalent Cases of Breast Cancer 74
4.6.2 Five-Year Diagnosed Prevalent Cases by Menopausal Status 76
4.6.3 Five-Year Diagnosed Prevalent Cases by Hormone Receptor Subtypes 77
4.7 Discussion 79
4.7.1 Epidemiological Forecast Insight 79
4.7.2 Limitations of the Analysis 81
4.7.3 Strengths of the Analysis 82
5 Disease Management 84
5.1 Diagnosis and Treatment Overview 84
5.1.1 Treatment of Early-Stage Breast Cancer (Stage 0 to Stage IB) 84
5.1.2 Treatment of Locally-Advanced and Regional Breast Cancer (Stage IB to IIIC) 86
5.1.3 Treatment Guidelines and Leading Prescribed Drugs 90
5.2 US 91
5.2.1 Diagnosis 91
5.2.2 Clinical Practice 92
5.3 France 95
5.3.1 Diagnosis 95
5.3.2 Clinical Practice 96
5.4 Germany 99
5.4.1 Diagnosis 99
5.4.2 Clinical Practice 100
5.5 Italy 103
5.5.1 Diagnosis 103
5.5.2 Clinical Practice 104
5.6 Spain 106
5.6.1 Diagnosis 106
5.6.2 Clinical Practice 107
5.7 UK 110
5.7.1 Diagnosis 110
5.7.2 Clinical Practice 111
5.8 Japan 114
5.8.1 Diagnosis 114
5.8.2 Clinical Practice 115
5.9 China 117
5.9.1 Diagnosis 117
5.9.2 Clinical Practice 119
6 Competitive Assessment 122
6.1 Overview 122
6.2 Product Profiles (Branded Therapies) 123
6.2.1 Abraxane (nab-paclitaxel) 123
6.2.2 Afinitor (everolimus) 128
6.2.3 Avastin (bevacizumab) 133
6.2.4 Doxil/Caelyx (pegylated liposomal doxorubicin) 137
6.2.5 Halaven (eribulin mesylate) 142
6.2.6 Ixempra (ixabepilone) 145
6.2.7 Xeloda (capecitabine) 148
6.3 Product Profiles (Hormonal Agents) 151
6.3.1 Tamoxifen 151
6.3.2 Faslodex (fulvestrant) 151
6.3.3 Aromatase Inhibitors 152
7 Unmet Need and Opportunity 156
7.1 Overview 156
7.1.1 Defined treatment plan for BRCA mutation-positive patients and prevention of prophylactic surgeries 158
7.1.2 Specific treatment options for TNBC patients 160
7.1.3 Prevention of brain metastasis 161
7.1.4 Neoadjuvant therapy that can downstage tumors 163
7.1.5 For HR+patients, reduced resistance to hormonal agents 164
7.1.6 Improved convenience of administration of hormonal agents 166
8 Pipeline Assessment 168
8.1 Overview 168
8.1.1 Abemaciclib (LY2835219) 169
8.1.2 Buparlisib (BKM- 120) 175
8.1.3 Javlor (vinflunine) 181
8.1.4 LEE011 185
8.1.5 NeuVax (nelipepimut-S/E75) 190
8.1.6 Niraparib (MK4827) 195
8.1.7 NKTR- 102 (etirinotecan pegol) 200
8.1.8 Lynparza (olaparib) 204
8.1.9 Palbociclib (PD-0332991) 209
8.1.10 Talazoparib (BMN 673) 215
8.1.11 Veliparib (ABT-888) 219
8.2 Promising Drugs in Clinical Development 224
8.2.1 PD-/PD-L 1 Immunotherapies 225
9 Current and Future Players 227
9.1 Overview 227
9.2 Trends in Corporate Strategy 229
9.3 Company Profiles 232
9.3.1 AstraZeneca 232
9.3.2 Bristol-Myers Squibb 233
9.3.3 Eli Lilly 235
9.3.4 Pfizer 236
9.3.5 Novartis/GlaxoSmithKline 239
10 Market Outlook 241
10.1 Global Markets 241
10.1.1 Forecast 241
10.1.2 Drivers and Barriers – Global Issues 247
10.2 US 249
10.2.1 Forecast 249
10.2.2 Key Events 252
10.2.3 Drivers and Barriers 253
10.3 France 255
10.3.1 Forecast 255
10.3.2 Key Events 258
10.3.3 Drivers and Barriers 259
10.4 Germany 260
10.4.1 Forecast 260
10.4.2 Key Events 264
10.4.3 Drivers and Barriers 265
10.5 Italy 266
10.5.1 Forecast 266
10.5.2 Key Events 270
10.5.3 Drivers and Barriers 271
10.6 Spain 272
10.6.1 Forecast 272
10.6.2 Key Events 275
10.6.3 Drivers and Barriers 276
10.7 UK 277
10.7.1 Forecast 277
10.7.2 Key Events 281
10.7.3 Drivers and Barriers 282
10.8 Japan 284
10.8.1 Forecast 284
10.8.2 Key Events 287
10.8.3 Drivers and Barriers 288
10.9 China 289
10.9.1 Forecast 289
10.9.2 Key Events 292
10.9.3 Drivers and Barriers 292
11 Appendix 294
11.1 Bibliography 294
11.2 Abbreviations 321
11.3 Methodology 329
11.4 Forecasting Methodology 329
11.4.1 Diagnosed HER2-Negative Breast Cancer Patients 329
11.4.2 Percentage of Drug-Treated Patients 330
11.4.3 Drugs Included in Each Therapeutic Class 330
11.4.4 Launch and Patent Expiry Dates 331
11.4.5 General Pricing Assumptions 332
11.4.6 Individual Drug Assumptions 334
11.4.7 Generic Erosion 342
11.4.8 Pricing of Pipeline Agents 342
11.5 Primary Research – KOLs Interviewed for This Report 353
11.6 Primary Research – High-Prescriber Survey 355
11.7 About the Authors 356
11.7.1 Analyst 356
11.7.2 Director of Oncology 356
11.7.3 Epidemiologist 357
11.7.4 Director of Epidemiology 357
11.7.5 Global Head of Healthcare 358
11.8 About GlobalData 359
11.9 Disclaimer 359
【レポート販売概要】
■ タイトル：HER2陰性乳癌治療薬の世界市場予測および分析■ 英文：PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023
■ 発行日：2015年1月31日
■ 調査会社：GlobalData
■ 商品コード：GDHC92PIDR
■ 調査対象地域：グローバル
- 全地形対応車(ATV)用変速機システムの世界市場2019-2023About this market The growing demand for ATVs in APAC will trigger the market’s growth in the forthcoming years. Emerging economies including India and China are witnessing an increase in the demand for ATVs in recent years mainly due to the growing awareness of applications of ATVs among the consumers. In addition, off-road enthusiasts are also increasingly looking for ATVs for engaging in off-ro …
- 産業用温度調整弁の世界市場ABSTRACTAbout Industrial Thermostatic Control Valves Industrial control valves are used for modulating the flow of fluid at varying degrees between minimal flow and full capacity after receiving a signal from the controllers. Control valves are considered as the critical part of any control loop, as they perform physical work by directly affecting the process parameter. Control valves further prov …
- Endeavour International Corporation：石油・ガスの開発・生産動向及びコスト分析– Q1, 2013Endeavour International Corporation Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary Endeavour International Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The r …
- 世界の光学的自動検査装置市場2015The Global Automated Optical Inspection Devices Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Automated Optical Inspection Devices industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automated Optical Inspection Devices market analysis is provided …
- Anterra Energy, Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Anterra Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Anterra Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- Mobility Aids and Transportation Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018Mobility Aids and Transportation Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Mobility Aids and Transportation Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Mobility Aids and Transportation Equipment market in the BRICS countries. The report provides …
- 世界のラベル市場動向：Global Label Market 2014-2018TechNavio's analysts forecast the Global Labels market to grow at a CAGR of 4.13 percent over the period 2014-2018. One of the key factors contributing to this market growth is the increasing demand for packaged food and beverages. The Global Labels market has also been witnessing the increasing demand from emerging countries. However, the highly fragmented nature of the market could pose a challe …
- FPGAの世界市場予測（～2022）The field programmable gate array (FPGA) market is expected to reach USD 7.23 Billion by 2022. FPGAs are expected to have many applications in automotive, consumer electronics, medical, and computing & data center verticals. Telecommunication, industrial, and aerospace & defense are currently, the top three markets for the application of FPGAs. FPGAs have many advantages such as fast time-to-marke …
- Lupus Nephritis：グローバル臨床試験レビューH1, 2013Lupus Nephritis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Lupus Nephritis Global Clinical Trials Review, H1, 2013" provides data on the Lupus Nephritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lupus Nephritis. It includes an overview of the trial numbers and their recruitment status as …
- 産業用保護手袋の世界市場2017-2021About Industrial Safety Glove Gloves are a form of personal protective equipment for hand and arms. Industrial safety gloves are mainly employed by workforce in industrial ecosystems. The factors driving this market include the global increase in rubber production, mainly in Malaysian region. Furthermore, the growth in various industrial segments have a positive impact on the market. The occupatio …
- ミュージックストリーミング（音楽配信）の世界市場2016-2020About Music Streaming Online music streaming enables real-time, uninterrupted access to music without downloading the files. Users can legally access high-quality songs for free for a pre-defined period or by paying a nominal subscription fee. The major advantage of the paid service is that it provides users with ad-free service. Emerging music streaming sites, high-speed internet, cloud technolog …
- 世界のジェスチャ認識市場動向（2012-2016）TechNavio's analysts forecast the Global Gesture Recognition market to grow at a CAGR of 26.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the ease of use in using gesture recognition-enabled devices. This is essential in the uptake of any new technology. The Global Gesture Recognition market has also been witnessing a growth because of the improv …
- レーザダイオードの世界市場：注入型レーザダイオード（ILD）、光励起半導体レーザ（OPSL）Laser diodes have become a key component of the modern photonics technology. This technology is dynamic and fast-developing, with new applications emerging continuously. The features of laser diodes such as compactness, high efficiency, and possibility of direct modulation with applied current among others distinguish them from other lasers. The increase in the demand for communication & data stor …
- 主要先進国におけるC型肝炎治療薬市場（～2019）Hepatitis C Therapeutics in Major Developed Markets to 2019 - Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape Summary GBI Research, has released the pharma report, “Hepatitis C Therapeutics in Major Developed Markets to 2019 - Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape”. The current Hepatit …
- 世界における小型自動車用電線（ワイヤー）市場（2008-2028）This latest just-auto report edition offers a global review of the OE electric and electronic distribution systems sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE electric and electronic distribution systems market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Pr …
